NewsDialy
Anthropic, the San Francisco-based artificial intelligence company behind the Claude family of models, announced Tuesday that it will enter drug development — a significant step that tests whether AI systems can do genuine scientific work, not just assist with it.
The announcement came at an event in San Francisco launching Claude Science, the company's newest application aimed at scientific research.
What Anthropic Is Actually Doing Drug development means a company identifies a molecule or biological target, tests whether it might treat a disease, and attempts to move it through a research pipeline.
Anthropic has not disclosed what therapeutic area or disease target it is pursuing.
Keep reading